Titre:
  • Antiagregantes plaquetarios e inhibidores de la bomba de protones. Cómo optimizar el riesgo-beneficio en los pacientes con riesgo cardiovascular y riesgo de hemorragia gastrointestinal?
Auteur:Casado Arroyo, Ruben; Muñoz-Villalenguas, María; Lanas Arbeloa, Angel
Informations sur la publication:Gastroenterología y hepatología, 34, 7, page (478-491)
Statut de publication:Publié, 2011
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Anti-Inflammatory Agents, Non-Steroidal -- adverse effects
Anti-Ulcer Agents -- therapeutic use
Aspirin -- adverse effects -- pharmacology -- therapeutic use
Cardiovascular Diseases -- epidemiology -- prevention & control
Cohort Studies
Dose-Response Relationship, Drug
Double-Blind Method
Drug Interactions
Drug Resistance
Female
Forecasting
Gastritis -- complications -- drug therapy
Gastrointestinal Hemorrhage -- chemically induced -- epidemiology -- prevention & control
Helicobacter Infections -- complications -- drug therapy
Helicobacter pylori
Humans
Male
Platelet Aggregation Inhibitors -- administration & dosage -- adverse effects -- pharmacology -- therapeutic use
Proton Pump Inhibitors -- adverse effects -- pharmacokinetics -- pharmacology -- therapeutic use
Randomized Controlled Trials as Topic
Risk
Risk Assessment
Ticlopidine -- adverse effects -- analogs & derivatives -- pharmacokinetics -- pharmacology -- therapeutic use
Note générale:English Abstract
Journal Article
Review
Langue:Espagnol
Identificateurs:urn:issn:0210-5705
info:doi/10.1016/j.gastrohep.2011.04.002
info:pii/S0210-5705(11)00213-5
info:pmid/21684042